Avant Technologies Begins Development on Next-Generation AI-Driven Resource Allocation Solution
LAS VEGAS, NEVADA, April 16, 2024 – Avant Technologies, Inc. (OTCQB: AVAI) (“Avant” or the “Company”), an artificial intelligence technology (AI) company specializing in the development of advanced AI and data center infrastructure solutions, announced today that development on its next-generation, AI-driven resource allocation system is fully underway. In February, Avant announced plans to begin […]
Rodedawg Intl. Ind, Inc. (OTC: RWGI) Provides Shareholder Update
Sales Channel Expansion Set for 2024 and Beyond COSTA MESA, CA, April 16th, 2024 - Rodedawg International Industries, Inc. (OTC: RWGI) proudly announces the Company, with our wholly owned subsidiary, Parabola Mgmt. LLC, has expanded into a multi-faceted cannabis enterprise. Chris Swartz, CEO, states, “Given all the progress in the past 6 months, we want […]
AMPG Files For Shelf Registration To Replace Expired Identical Shelf Without Dilution, Reinforcing Financial Stability
HAUPPAUGE, NY, April 16, 2024 – AmpliTech Group, Inc (Nasdaq: AMPG), a designer, developer, and manufacturer of state-of-the-art signal-processing components for satellite, 5G, and other communications networks, including the design of complete 5G/6G systems, and a global distributor of packages and lids for integrated circuit assembly, today announced it has filed with SEC a shelf registration […]
PRISM MarketView – Biotech Breakfast
Mobile-Health Network Solutions (MNDR) IPOs; Q32 Bio Surges; EMA Concludes GLP-1 Drugs Not Associated with Suicidal Thoughts New York, N.Y., April 15, 2024 – PRISM MarketView – Healthcare equities finished lower on Friday, in line with broad declines across the market. The S&P 500 Healthcare Index closed down (1.52%) versus the S&P 500 Index which lost […]
ONCOCYTE REPORTS Full Year 2023 FINANCIAL RESULTS
Conference Call on Friday, April 12, 2024 at 5:00 a.m. PT / 8:00 a.m. ET IRVINE, CA, April 12, 2024 – Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, today reported financial results for the year ended December 31, 2023. Recent Highlights “In 2023, we made significant progress on cost controls and in the development of […]
American Shared Hospital Services Announces the Sudden Passing of CEO, Peter Gaccione
SAN FRANCISCO, CA, April 12, 2024 – American Shared Hospital Services (NYSE American: AMS) (the “Company”), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services, today announces the sudden passing of its Chief Executive Officer, Peter Gaccione. Ray Stachowiak, Executive Chairman of American Shared Hospital Services, said, […]
Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules
IRVINE, CA, April 11, 2024 – Oncocyte Corporation (NASDAQ: OCX), (“Oncocyte” or the “Company”), a precision diagnostics company, today announced that it has entered into definitive securities purchase agreements (the “Purchase Agreements”) for the purchase and sale of an aggregate of 5,077,387 shares of common stock, at a purchase price of $ 2.9164 per share […]
Auto Parts 4 Less Group Inc. Announces Strategic Investment from RB Capital to Fuel Growth and Innovation
Las Vegas, NV, April 11, 2024 – Auto Parts 4 Less Group, Inc. (OTC: FLES) (“AutoParts4Less,” “the Company”), a technology-driven e-commerce leader in the automotive parts sector, announces Investment from RB Capital. AutoParts4Less is excited to announce today that it has completed the first tranche of funding from RB Capital Partners, following the successful restructuring […]
Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay
– Bio-Rad expects to make equity investment in support of deal – Agreement provides for global exclusivity in transplant monitoring commercialization – Bio-Rad granted subsequent investment option upon FDA clearance IRVINE, CA, April 11, 2024 – Oncocyte Corporation (NASDAQ: OCX), a precision diagnostics company, today announced a partnership agreement with Bio-Rad Laboratories (NYSE: BIO), a […]
SS Innovations’ Flagship SSi Mantra Surgical Robotic Device Successfully Completes Telesurgery Procedures
First-ever telesurgery using SSi Mantra performed on an animal in India FORT LAUDERDALE, FL, April 10, 2024 – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making world class robotic surgery affordable and accessible to a global population, today announced that its SSi […]